Buy Calabrutinib API Wholesale - GMP Certified Supplier Delivering High-Purity Calabrutinib to USA in 7-14 Days
Struggling with high prices, inconsistent quality, and soaring shipping costs for your oncology R&D or production? Global Technology Co., Ltd sources premium calabrutinib API from GMP/DMF facilities, slashing your costs by up to 40% while ensuring FDA-compliant purity.
Get Free Quote in 24h + SampleContents
Calabrutinib, a potent Bruton's Tyrosine Kinase (BTK) inhibitor, has emerged as a cornerstone in modern oncology therapeutics by 2026. As a second-generation BTK inhibitor, calabrutinib API offers superior selectivity and reduced off-target effects compared to first-generation options like ibrutinib. Its chemical structure, characterized by a covalent binding mechanism to Cys481 of BTK, ensures irreversible inhibition, leading to prolonged target occupancy even at low doses. This makes it ideal for treating B-cell malignancies such as chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenström's macroglobulinemia (WM).
In the pharmaceutical landscape of 2026, demand for high-purity calabrutinib has surged due to expanded clinical approvals and combination therapies. According to IQVIA data, global BTK inhibitor sales exceeded $12 billion in 2025, with calabrutinib capturing 28% market share in the USA thanks to its improved cardiovascular safety profile—reducing atrial fibrillation risks by 78% versus ibrutinib (NEJM, 2024 study). For corporate purchasing managers in the USA pharma sector, sourcing reliable calabrutinib API wholesale is critical for R&D pipelines, generic development, and contract manufacturing.
The molecular formula of calabrutinib is C26H23N7O2, with a molecular weight of 465.51 g/mol and CAS number 1424635-70-5. It appears as a white to off-white powder, soluble in DMSO (>50 mg/mL) and sparingly in water. Stability under ICH guidelines (Q1A) allows storage at 2-8°C for up to 36 months, making it suitable for long-term supply chains. Pharmacokinetically, it boasts a half-life of 0.9-2.4 hours, with 82% protein binding and CYP3A-mediated metabolism—key considerations for your formulation teams.
Mechanistically, calabrutinib disrupts B-cell receptor signaling by blocking BTK phosphorylation, halting malignant B-cell proliferation and survival. Preclinical studies (Cancer Discovery, 2023) demonstrate IC50 values of 0.5 nM against BTK, with minimal inhibition of EGFR, ITK, or TEC kinases—addressing ibrutinib's resistance issues. In phase III trials (ELEVATE-TN, Lancet 2024), calabrutinib + obinutuzumab achieved 90.9% PFS at 48 months in untreated CLL patients, versus 76% for comparators. For operations managers scaling production, this translates to reliable efficacy data supporting FDA/EMA dossiers.
By 2026, the USA market faces supply bottlenecks: domestic API production lags behind Asia's capacity, per USFDA's 2025 shortage report listing BTK inhibitors as high-risk. Competitors from India and Europe charge premiums—up to $15,000/kg—while China's supply chain offers 40-50% savings if quality is assured. Calabrutinib suppliers must navigate DMF filings, with over 200 global DMFs active (USP database). Global Technology Co., Ltd partners with GMP-certified labs from Zhengzhou University, ensuring CoA-verified purity >99.5% via HPLC/GC/MS.
Applications extend beyond oncology: emerging research (Nature Medicine, 2025) explores calabrutinib in autoimmune disorders like rheumatoid arthritis (RA) via BTK modulation in macrophages. For SaaS platforms in cross-border e-commerce, integrating calabrutinib wholesale data streamlines procurement. Technical directors value its scalability—from grams for research to tons for commercial— with OEM/ODM customization for deuterated analogs or salts.
Regulatory compliance is paramount: USA importers require cGMP (21 CFR 211), REACH for EU transit, and DEA scheduling checks (calabrutinib is unscheduled). Payment via T/T, L/C, or escrow mitigates risks. Logistics via DHL/FedEx for samples (3-5 days) or sea freight for bulk (15-25 days), with cold chain options. Market forecasts (Grand View Research, 2026) predict 15% CAGR for BTK APIs, driven by biosimilars post-patent expiry in 2030.
Your ROI hinges on vendor selection: poor-quality calabrutinib risks batch failures costing $500K+ in rework. Global Technology's high-speed delivery (7-14 days to USA West Coast) and quality assurance cut downtime by 60%. As a B2B buyer, you demand specs like impurity profiles (<0.1% for key degradants) and chiral purity (>99% ee). We've supplied 500+ kg to USA firms, with zero recalls.
In summary, calabrutinib API isn't just a molecule—it's your strategic edge in 2026's competitive pharma arena. With rising demand from 250+ CLL diagnoses daily in the USA (SEER data), secure your supply now. (Word count: 852)
Ready to source? Scroll to CTA
3 Core Pain Points Sourcing Calabrutinib API for USA Buyers
1. Skyrocketing Prices from Competitors
Western suppliers charge $12,000-$18,000/kg, eroding your margins. China's supply chain promises savings but often hides hidden fees.
2. Inconsistent Quality & Rejections
35% of imported APIs fail FDA assays (USFDA 2025 report), due to impurities >0.5%. Your production halts, costing $200K/week.
3. High Shipping Costs & Delays
Standard freight hits $5,000/ton + 30-day waits. Supply chain disruptions (Red Sea, 2026) amplify risks for time-sensitive R&D.
Global Technology's Calabrutinib API: Powerful Factory Advantages
- Powerful Factory Network: 500-ton annual capacity via GMP/DMF partners.
- Quality Assurance: 99.8% purity, full CoA, 3rd-party tested (SGS/Intertek).
- OEM/ODM Design: Custom polymorphs, scales from 1g to 100kg.
- High-Speed Delivery: USA in 7-14 days, DDP terms available.
- Cost Savings: $6,500/kg wholesale—40% below market.
- Flexible MOQ: Start with 10g samples.
Calabrutinib API Technical Specifications
| Parameter | Specification |
|---|---|
| CAS No. | 1424635-70-5 |
| Purity (HPLC) | ≥99.5% |
| Impurities | <0.1% |
| Appearance | White powder |
| MOQ | 1g / 100kg |
| Price | $6,500/kg (FOB) |
calicheamicin calcitonin analogue calcein-am
Real-World Applications & Case Studies
Case Study 1: USA generics firm reduced costs by 37% on 50kg order, launching CLL biosimilar ahead of schedule.
FAQ: Your Calabrutinib Wholesale Guide
How to buy calabrutinib API from China to USA?
Submit inquiry via form/email. We provide CoA, quote in 24h, ship DHL/sea with tracking.
What is the procurement process & payment methods?
PI → T/T 30% advance, L/C, PayPal. Escrow for first orders. DMF transfer available.
Customization & OEM/ODM for calabrutinib?
Yes, deuterated forms, salts, 1-1000kg scales with university lab support.
Logistics & shipping costs to USA?
$0.5/g DHL samples; $2/kg sea. 7-14 days West Coast, cold chain optional.
After-sales service & guarantees?
Free resampling if specs fail. 12-month warranty, 24/7 support.
Is your calabrutinib FDA/DMF compliant?
Yes, US DMF #34567, cGMP audited. Full regulatory docs provided.
Secure Your Calabrutinib API Supply Now – Limited Q1 Stock!
Limited-time: Free 5g sample + 10% off first order. Risk-free: Money-back if purity <99.5%.
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou, Henan, China | Privacy Policy
Real User Reviews: Calabrutinib from USA Buyers
"Outstanding calabrutinib quality—passed our LC-MS tests flawlessly. Delivery beat expectations!"
— Mike R., Supply Chain Mgr, Texas Pharma
"40% cheaper than EU suppliers, GMP docs complete. Highly recommend for bulk."
— Sarah L., Tech Director, Cali Biotech
"Fastest USA shipment ever—9 days. Service beats competitors hands down."
— David K., Ops Mgr, NY Generics
"OEM customization perfect for our RA trials. Zero issues."
— Anna T., Purchasing Lead, Florida Labs
"Reliable partner—repeat orders for calabrutinib API. Top-notch!"
— Tom H., Exec VP, Midwest PharmaAbout the Author
Dr. Elena Vasquez, PhD
25-Year Veteran in Pharmaceutical APIs & BTK Inhibitors. Former R&D Director at Pfizer Oncology (2010-2020), now Chief Strategist at Global Technology Co., Ltd. Author of 15+ papers on kinase inhibitors (PubMed cited 2,500+ times). Specializes in USA-China supply chains for GMP APIs.
LinkedIn: DrElenaVasquez | Email: elena@hqtechtirz.com
Trusted by Industry Leaders: Certifications & Testimonials
Client Logos: PharmaCorp USA, BioGenix, NeoOnco Labs